These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 7549057

  • 1. The optimal immunosuppressant after liver transplantation according to diagnosis: cyclosporine A or FK506?
    Mueller AR, Platz KP, Blumhardt G, Bechstein WO, Steinmüller T, Christe W, Hopf U, Lobeck H, Neuhaus P.
    Clin Transplant; 1995 Jun; 9(3 Pt 1):176-84. PubMed ID: 7549057
    [Abstract] [Full Text] [Related]

  • 2. Toxicity versus rejection--or why conversions between cyclosporine A and FK506 were performed after liver transplantation.
    Platz KP, Mueller AR, Jonas S, Blumhardt G, Bechstein WO, Lobeck H, Neuhaus HL.
    Clin Transplant; 1995 Jun; 9(3 Pt 1):146-54. PubMed ID: 7549052
    [Abstract] [Full Text] [Related]

  • 3. FK506 effectiveness in reducing acute rejection after heart transplantation: a prospective randomized study.
    Rinaldi M, Pellegrini C, Martinelli L, Goggi C, Gavazzi A, Campana C, Arbustini E, Grossi P, Regazzi M, Ippoliti G, Vigano M.
    J Heart Lung Transplant; 1997 Oct; 16(10):1001-10. PubMed ID: 9361242
    [Abstract] [Full Text] [Related]

  • 4. Rejection episodes after liver transplantation during primary immunosuppression with FK506 or a cyclosporine-based regimen: a controlled, prospective, randomized trial.
    Jonas S, Kling N, Bechstein WO, Blumhardt G, Lohmann R, Lobeck H, Neuhaus P.
    Clin Transplant; 1995 Oct; 9(5):406-14. PubMed ID: 8541635
    [Abstract] [Full Text] [Related]

  • 5. Neurotoxicity after orthotopic liver transplantation. A comparison between cyclosporine and FK506.
    Mueller AR, Platz KP, Bechstein WO, Schattenfroh N, Stoltenburg-Didinger G, Blumhardt G, Christe W, Neuhaus P.
    Transplantation; 1994 Jul 27; 58(2):155-70. PubMed ID: 7518974
    [Abstract] [Full Text] [Related]

  • 6. [Clinical study of tacrolimus in postoperative treatment of patients with renal transplantation for diabetic end-stage renal disease].
    Yu LX, Shan HT, Fu SJ, Du CF, Ma JJ, Xu J, Deng WF, Wang YB.
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Nov 27; 23(11):1146-8. PubMed ID: 14625173
    [Abstract] [Full Text] [Related]

  • 7. Nephrotoxicity following orthotopic liver transplantation. A comparison between cyclosporine and FK506.
    Platz KP, Mueller AR, Blumhardt G, Bachmann S, Bechstein WO, Kahl A, Neuhaus P.
    Transplantation; 1994 Jul 27; 58(2):170-8. PubMed ID: 7518975
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
    Krämer BK, Montagnino G, Del Castillo D, Margreiter R, Sperschneider H, Olbricht CJ, Krüger B, Ortuño J, Köhler H, Kunzendorf U, Stummvoll HK, Tabernero JM, Mühlbacher F, Rivero M, Arias M, European Tacrolimus vs Cyclosporin Microemulsion Renal Transplantation Study Group.
    Nephrol Dial Transplant; 2005 May 27; 20(5):968-73. PubMed ID: 15741208
    [Abstract] [Full Text] [Related]

  • 9. Comparison of FK506- and cyclosporine-based immunosuppression in primary orthotopic liver transplantation. A single center experience.
    Neuhaus P, Blumhardt G, Bechstein WO, Platz KP, Jonas S, Mueller AR, Langrehr JM, Lohmann R, Schattenfroh N, Knoop M.
    Transplantation; 1995 Jan 15; 59(1):31-40. PubMed ID: 7530868
    [Abstract] [Full Text] [Related]

  • 10. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
    Yu S, He X, Yang L, Ma Y, Zhu X, Ju W, Huang J.
    Exp Clin Transplant; 2008 Jun 15; 6(2):113-7. PubMed ID: 18816237
    [Abstract] [Full Text] [Related]

  • 11. Loss of nocturnal blood pressure fall after liver transplantation during immunosuppressive therapy.
    Taler SJ, Textor SC, Canzanello VJ, Wilson DJ, Wiesner RH, Krom RA.
    Am J Hypertens; 1995 Jun 15; 8(6):598-605. PubMed ID: 7544983
    [Abstract] [Full Text] [Related]

  • 12. Early steroid withdrawal after liver transplantation: the Canadian tacrolimus versus microemulsion cyclosporin A trial: 1-year follow-up.
    Greig P, Lilly L, Scudamore C, Erb S, Yoshida E, Kneteman N, Bain V, Ghent C, Marotta P, Grant D, Wall W, Tchervenkov J, Barkun J, Roy A, Marleau D, McAlister V, Peltekian K.
    Liver Transpl; 2003 Jun 15; 9(6):587-95. PubMed ID: 12783400
    [Abstract] [Full Text] [Related]

  • 13. Incidence of rejection and infection after liver transplantation as a function of the primary disease: possible influence of alcohol and polyclonal immunoglobulins.
    Farges O, Saliba F, Farhamant H, Samuel D, Bismuth A, Reynes M, Bismuth H.
    Hepatology; 1996 Feb 15; 23(2):240-8. PubMed ID: 8591847
    [Abstract] [Full Text] [Related]

  • 14. Long-term evaluation of cyclosporine and tacrolimus based immunosuppression in pediatric liver transplantation.
    Hasenbein W, Albani J, Englert C, Spehr A, Grabhorn E, Kemper MJ, Burdelski M, Ganschow R.
    Pediatr Transplant; 2006 Dec 15; 10(8):938-42. PubMed ID: 17096762
    [Abstract] [Full Text] [Related]

  • 15. Primary immunosuppression with tacrolimus in kidney transplantation: three-year follow-up in a single center.
    Kim HC, Hwang EA, Han SY, Park SB, Kim HT, Cho WH.
    Transplant Proc; 2004 Sep 15; 36(7):2082-3. PubMed ID: 15518753
    [Abstract] [Full Text] [Related]

  • 16. Increased incidence of early de novo cancer in liver graft recipients treated with cyclosporine: an association with C2 monitoring and recipient age.
    Tjon AS, Sint Nicolaas J, Kwekkeboom J, de Man RA, Kazemier G, Tilanus HW, Hansen BE, van der Laan LJ, Tha-In T, Metselaar HJ.
    Liver Transpl; 2010 Jul 15; 16(7):837-46. PubMed ID: 20583092
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and safety of tacrolimus compared with ciclosporin A in renal transplantation: three-year observational results.
    Krämer BK, Del Castillo D, Margreiter R, Sperschneider H, Olbricht CJ, Ortuño J, Sester U, Kunzendorf U, Dietl KH, Bonomini V, Rigotti P, Ronco C, Tabernero JM, Rivero M, Banas B, Mühlbacher F, Arias M, Montagnino G, European Tacrolimus versus Ciclosporin Microemulsion Renal Transplantation Study Group.
    Nephrol Dial Transplant; 2008 Jul 15; 23(7):2386-92. PubMed ID: 18258740
    [Abstract] [Full Text] [Related]

  • 18. Tacrolimus compared with cyclosporine microemulsion in primary simultaneous pancreas-kidney transplantation: the EURO-SPK 3-year results.
    Malaise J, Saudek F, Boucek P, Adamec M, Van Ophem D, Squifflet JP, EUROSPK Study Group.
    Transplant Proc; 2005 Jul 15; 37(6):2843-5. PubMed ID: 16182828
    [Abstract] [Full Text] [Related]

  • 19. Experience of FK506 immune suppression in pediatric heart transplantation: a study of long-term adverse effects.
    Asante-Korang A, Boyle GJ, Webber SA, Miller SA, Fricker FJ.
    J Heart Lung Transplant; 1996 Apr 15; 15(4):415-22. PubMed ID: 8732602
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and safety of tacrolimus versus cyclosporine microemulsion in primary cardiac transplant recipients: 6-month results in Taiwan.
    Wang CH, Ko WJ, Chou NK, Wang SS.
    Transplant Proc; 2004 Oct 15; 36(8):2384-5. PubMed ID: 15561256
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.